Clinical trials recruiting in Distrito Federal, Mexico
6
Recruiting trials
8
Conditions
Phase breakdown
Phase 2 1Phase 3 5
Conditions recruiting in Distrito Federal, Mexico
| Condition | Trials |
|---|---|
| Breast Cancer | 3 |
| Diabetes Mellitus | 1 |
| Heart Failure | 1 |
| Lung cancer | 1 |
| Non-small Cell Lung Cancer | 1 |
| Obesity | 1 |
| Overweight | 1 |
| Type 2 diabetes | 1 |
Recruiting trials in Distrito Federal, Mexico
- A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
- A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Common questions
How many clinical trials are recruiting in Distrito Federal, Mexico?
6 recruiting trials have at least one study site in Distrito Federal, Mexico.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.